Seeking heterocyclic scaffolds as antivirals against dengue virus

Eur J Med Chem. 2022 Jul 3;240:114576. doi: 10.1016/j.ejmech.2022.114576. Online ahead of print.ABSTRACTDengue is one of the most typical viral infection categorized in the Neglected Tropical Diseases (NTDs). It is transmitted via the female Aedes aegypti mosquito to humans and majorly puts risk to the lives of more than half of the world. Recent advancements in medicinal chemistry have led to the design and development of numerous potential heterocyclic scaffolds as antiviral drug candidates for the inhibition of the dengue virus (DENV). Thus, in this review, we have discussed the significance of inhibitory and antiviral activities of nitrogen, oxygen, and mixed (nitrogen-sulfur and nitrogen-oxygen) heterocyclic scaffolds that are published in the last seven years (2016-2022). Furthermore, we have also discussed the probable mechanisms of action and the diverse structure-activity relationships (SARs) of the heterocyclic scaffolds. In addition, this review has elaborately outlined the mechanism of viral infection and the life cycle of DENV in the host cells. The wide set of heterocycles and their SARs will aid in the development of pharmaceuticals that will allow the researchers to synthesize the promising anti-dengue drug candidate in the future.PMID:35816877 | DOI:10.1016/j.ejmech.2022.114576

Source: European Journal of Medicinal Chemistry - July 11, 2022 Category: Chemistry Authors: Soumik De Bari Aamna Raghaba Sahu Sagarika Parida Santosh Kumar Behera Aritra Kumar Dan Source Type: research